Delivery Order SPE2DB22D2206-SPE2DB25FEE85
Award Date
11/12/24
Potential Completion Date
11/13/24
Potential Value
$80K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ENBREL 50 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $21,076.07. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as...
This federal contract award is for the delivery of ENBREL 50 MG/ML SYRINGES to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $18,253.52, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has a firm fixed price pricing type and a completion date of May 22, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued...
This federal contract award is for the delivery of ENBREL 50 MG/ML syringes to the Defense Logistics Agency (DLA). The contract, valued at $11,098.88, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 21, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of ENBREL 50 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency. The $7,006.87 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of April 3, 2025 and was not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award is for the delivery of ENBREL 50 MG/ML SYRINGEML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $95,114.82 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of January 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The federal contract award is for the delivery of ENBREL 50 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency. The $9,371.66 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and was not set aside for a specific business type. The contract has an ultimate completion date of August 19, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This federal contract award is for the delivery of ENBREL 50 MG/ML syringes to the Defense Logistics Agency (DLA). The contract, valued at $45,812.70, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of November 15, 2024. There was no set-aside designation used for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of ENBREL 50 MG/ML syringes to the Defense Logistics Agency (DLA), a component of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $18,697.28 and has an ultimate completion date of April 17, 2024. Amerisourcebergen holds a significant $999,999,999.00...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $92,814.47, is for the provision of ENBREL 50 MG/ML SYRINGEML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of January 3, 2025. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of the pharmaceutical product ENBREL 50 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a Defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a Delivery Order with a Firm Fixed Price of $8,304.28 and a completion date of June 18, 2024. This award is not associated with a set-aside designation. Amerisourcebergen...